AVNS
Avanos Medical, Inc.
Price Chart
Latest Quote
$24.93
-0.03 (-0.12%)
Current Price
| Previous Close | $24.96 |
| Open | $24.95 |
| Day High | $24.95 |
| Day Low | $24.92 |
| Volume | 395,213 |
Stock Information
| Shares Outstanding | 46.85M |
| Total Debt | $138.40M |
| Cash Equivalents | $65.60M |
| Revenue | $715.90M |
| Net Income | $-74.40M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.17B |
| EPS (TTM) | $-1.60 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.24B |
| Sales | $715.90M |
| Income | $-74.40M |
| Book/sh | $16.76 |
| Cash/sh | $1.40 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.28 |
| Current Ratio | 2.48 |
| Debt/Eq | 17.70 |
| EPS Growth TTM | -22.70% |
Returns & Margins
| ROA | 0.95% |
| ROE | -9.18% |
| Gross Margin | 50.05% |
| Operating Margin | 5.38% |
| Profit Margin | -10.39% |
Ownership
| Insider Ownership | 3.28% |
| Institutional Ownership | 90.83% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 19.94 |
| P/S | 1.63 |
| P/B | 1.49 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $24.90 |
| SMA50 | $23.93 |
| SMA200 | $15.30 |
| RSI | 63.93 |
| ATR | 0.1293 |
| Shares Float | 46.00M |
| Short Float | 3.32% |
| Short Ratio | 0.97 |
| Volatility | 1.57 |
| Rel Volume | 0.30 |
Performance History
| Week | -0.20% |
| Month | +0.77% |
| Quarter | +85.22% |
| 6 Months | +110.20% |
| YTD | +122.99% |
| Year | +103.84% |
| 3 Years | -1.73% |
| 5 Years | -37.74% |
| 10 Years | -22.58% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $24.93 | 395,213 |
| 2026-06-16 | $24.96 | 705,500 |
| 2026-06-15 | $24.96 | 532,900 |
| 2026-06-12 | $24.96 | 360,500 |
| 2026-06-11 | $24.98 | 1,279,000 |
| 2026-06-10 | $24.98 | 629,200 |
| 2026-06-09 | $25.03 | 703,000 |
| 2026-06-08 | $25.00 | 894,700 |
| 2026-06-05 | $25.05 | 823,300 |
| 2026-06-04 | $25.00 | 1,409,300 |
| 2026-06-03 | $24.98 | 2,349,600 |
| 2026-06-02 | $24.99 | 3,246,300 |
| 2026-06-01 | $25.05 | 3,534,200 |
| 2026-05-29 | $24.80 | 988,600 |
| 2026-05-28 | $24.76 | 643,700 |
| 2026-05-27 | $24.79 | 834,800 |
| 2026-05-26 | $24.75 | 1,167,900 |
| 2026-05-22 | $24.61 | 3,552,300 |
| 2026-05-21 | $24.70 | 1,346,600 |
| 2026-05-20 | $24.74 | 751,000 |
| 2026-05-19 | $24.75 | 625,100 |
| 2026-05-18 | $24.74 | 849,600 |
About Avanos Medical, Inc.
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
đ° Latest News
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-06-04T15:30:08Z
A Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price Surge
Simply Wall St. âĸ 2026-06-04T09:11:57Z
New Strong Sell Stocks for May 15th
Zacks âĸ 2026-05-15T10:04:00Z
Deciphering Avanos Medical (AVNS) International Revenue Trends
Zacks âĸ 2026-05-11T13:15:02Z
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
Zacks âĸ 2026-05-07T15:35:00Z
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
Zacks âĸ 2026-05-05T12:25:03Z
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-04T21:50:07Z
Nanox To Deploy 300 Nanox.ARC Systems in The U.S. Over 3 Years
Exec Edge âĸ 2026-04-23T22:07:38Z
Is It Too Late To Consider Buying Avanos Medical (AVNS) After Its Recent Share Price Surge?
Simply Wall St. âĸ 2026-04-19T22:04:49Z
Nanox Continues Expanding Nanox.ARC in U.S. & Israel
Exec Edge âĸ 2026-04-16T21:33:58Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $347,300,000 | $306,500,000 | $293,600,000 | $289,900,000 |
| Cost Of Revenue | $347,300,000 | $306,500,000 | $293,600,000 | $289,900,000 |
| Total Revenue | $701,200,000 | $687,800,000 | $673,300,000 | $684,100,000 |
| Operating Revenue | $701,200,000 | $687,800,000 | $673,300,000 | $684,100,000 |
| Expenses | ||||
| Interest Expense | $7,800,000 | $12,200,000 | $15,000,000 | $10,000,000 |
| Total Expenses | $685,800,000 | $647,300,000 | $669,100,000 | $648,600,000 |
| Other Income Expense | $-77,000,000 | $-436,700,000 | - | - |
| Net Non Operating Interest Income Expense | $-4,600,000 | $-7,100,000 | $-12,100,000 | $-8,800,000 |
| Interest Expense Non Operating | $7,800,000 | $12,200,000 | $15,000,000 | $10,000,000 |
| Operating Expense | $338,500,000 | $340,800,000 | $375,500,000 | $358,700,000 |
| Other Operating Expenses | $-400,000 | $-3,900,000 | $13,300,000 | $3,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-72,900,000 | $-386,300,000 | $-9,900,000 | $21,500,000 |
| Net Interest Income | $-4,600,000 | $-7,100,000 | $-12,100,000 | $-8,800,000 |
| Interest Income | $3,200,000 | $5,100,000 | $2,900,000 | $1,200,000 |
| Normalized Income | $-12,070,000 | $31,992,115 | $-9,900,000 | $21,500,000 |
| Net Income From Continuing And Discontinued Operation | $-72,900,000 | $-392,100,000 | $-61,800,000 | $50,500,000 |
| Total Operating Income As Reported | $-61,600,000 | $-396,200,000 | $4,200,000 | $35,500,000 |
| Net Income Common Stockholders | $-72,900,000 | $-392,100,000 | $-61,800,000 | $50,500,000 |
| Net Income | $-72,900,000 | $-392,100,000 | $-61,800,000 | $50,500,000 |
| Net Income Including Noncontrolling Interests | $-72,900,000 | $-392,100,000 | $-61,800,000 | $50,500,000 |
| Net Income Discontinuous Operations | $0 | $-5,800,000 | $-51,900,000 | $29,000,000 |
| Net Income Continuous Operations | $-72,900,000 | $-386,300,000 | $-9,900,000 | $21,500,000 |
| Pretax Income | $-66,200,000 | $-403,300,000 | $-7,900,000 | $26,700,000 |
| Special Income Charges | $-77,000,000 | $-436,700,000 | $0 | $0 |
| Interest Income Non Operating | $3,200,000 | $5,100,000 | $2,900,000 | $1,200,000 |
| Operating Income | $15,400,000 | $40,500,000 | $4,200,000 | $35,500,000 |
| Gross Profit | $353,900,000 | $381,300,000 | $379,700,000 | $394,200,000 |
| Per Share | ||||
| Diluted EPS | $-1.57 | $-8.53 | $-1.32 | $1.07 |
| Basic EPS | $-1.57 | $-8.53 | $-1.32 | $1.08 |
| Other | ||||
| Tax Effect Of Unusual Items | $-16,170,000 | $-18,407,885 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $57,500,000 | $91,100,000 | $53,200,000 | $84,400,000 |
| Total Unusual Items | $-77,000,000 | $-436,700,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-77,000,000 | $-436,700,000 | $0 | $0 |
| Reconciled Depreciation | $38,900,000 | $45,500,000 | $46,100,000 | $47,700,000 |
| EBITDA (Bullshit earnings) | $-19,500,000 | $-345,600,000 | $53,200,000 | $84,400,000 |
| EBIT | $-58,400,000 | $-391,100,000 | $7,100,000 | $36,700,000 |
| Diluted Average Shares | $46,300,000 | $46,000,000 | $46,600,000 | $47,300,000 |
| Basic Average Shares | $46,300,000 | $46,000,000 | $46,600,000 | $46,900,000 |
| Diluted NI Availto Com Stockholders | $-72,900,000 | $-392,100,000 | $-61,800,000 | $50,500,000 |
| Tax Provision | $6,700,000 | $-17,000,000 | $2,000,000 | $5,200,000 |
| Impairment Of Capital Assets | $77,000,000 | $436,700,000 | $0 | $0 |
| Research And Development | $23,300,000 | $26,200,000 | $27,200,000 | $29,200,000 |
| Selling General And Administration | $315,600,000 | $318,500,000 | $335,000,000 | $326,500,000 |
Fetched: 2026-06-10
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $265,500,000 | $260,600,000 | $200,700,000 | $296,700,000 |
| Total Assets | $1,073,700,000 | $1,154,200,000 | $1,692,400,000 | $1,786,900,000 |
| Total Non Current Assets | $718,300,000 | $760,800,000 | $1,205,400,000 | $1,162,800,000 |
| Other Non Current Assets | $31,500,000 | $23,200,000 | $19,300,000 | $17,600,000 |
| Non Current Deferred Assets | $33,100,000 | $24,900,000 | $6,500,000 | $4,600,000 |
| Non Current Deferred Taxes Assets | $33,100,000 | $24,900,000 | $6,500,000 | $4,600,000 |
| Goodwill And Other Intangible Assets | $512,700,000 | $567,900,000 | $1,035,600,000 | $994,500,000 |
| Other Intangible Assets | $117,800,000 | $112,300,000 | $239,500,000 | $234,200,000 |
| Current Assets | $355,400,000 | $393,400,000 | $487,000,000 | $624,100,000 |
| Other Current Assets | $13,800,000 | $14,100,000 | $28,800,000 | $13,900,000 |
| Inventory | $148,000,000 | $138,800,000 | $163,200,000 | $132,300,000 |
| Receivables | $103,800,000 | $132,800,000 | $142,800,000 | $167,900,000 |
| Taxes Receivable | $100,000 | $4,900,000 | $14,100,000 | $12,200,000 |
| Accounts Receivable | $103,700,000 | $127,900,000 | $128,700,000 | $155,700,000 |
| Allowance For Doubtful Accounts Receivable | $-4,300,000 | $-5,700,000 | $-5,300,000 | $-6,400,000 |
| Gross Accounts Receivable | $108,000,000 | $133,600,000 | $134,000,000 | $162,100,000 |
| Cash Cash Equivalents And Short Term Investments | $89,800,000 | $107,700,000 | $87,700,000 | $127,700,000 |
| Cash And Cash Equivalents | $89,800,000 | $107,700,000 | $87,700,000 | $127,700,000 |
| Assets Held For Sale Current | - | $0 | $64,500,000 | $182,300,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $10,700,000 | $27,000,000 | $80,300,000 | $104,800,000 |
| Total Debt | $129,100,000 | $170,200,000 | $209,100,000 | $277,000,000 |
| Long Term Debt And Capital Lease Obligation | $110,700,000 | $149,900,000 | $187,700,000 | $258,800,000 |
| Long Term Debt | $90,300,000 | $125,300,000 | $159,400,000 | $226,300,000 |
| Current Debt And Capital Lease Obligation | $18,400,000 | $20,300,000 | $21,400,000 | $18,200,000 |
| Current Debt | $10,200,000 | $9,400,000 | $8,600,000 | $6,200,000 |
| Other Current Borrowings | $10,200,000 | $9,400,000 | $8,600,000 | $6,200,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $295,500,000 | $325,700,000 | $456,100,000 | $495,700,000 |
| Total Non Current Liabilities Net Minority Interest | $130,300,000 | $159,800,000 | $221,500,000 | $304,700,000 |
| Other Non Current Liabilities | $9,500,000 | $200,000 | $4,100,000 | $15,700,000 |
| Non Current Deferred Liabilities | $6,100,000 | $5,500,000 | $23,800,000 | $25,400,000 |
| Non Current Deferred Taxes Liabilities | $6,100,000 | $5,500,000 | $23,800,000 | $25,400,000 |
| Current Liabilities | $165,200,000 | $165,900,000 | $234,600,000 | $191,000,000 |
| Payables And Accrued Expenses | $146,800,000 | $145,600,000 | $149,500,000 | $165,700,000 |
| Payables | $72,400,000 | $72,300,000 | $73,000,000 | $89,100,000 |
| Total Tax Payable | $16,900,000 | $18,000,000 | $16,700,000 | $21,200,000 |
| Accounts Payable | $55,500,000 | $54,300,000 | $56,300,000 | $67,900,000 |
| Other Current Liabilities | - | - | $63,700,000 | $7,100,000 |
| Tradeand Other Payables Non Current | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $778,200,000 | $828,500,000 | $1,236,300,000 | $1,291,200,000 |
| Total Equity Gross Minority Interest | $778,200,000 | $828,500,000 | $1,236,300,000 | $1,291,200,000 |
| Stockholders Equity | $778,200,000 | $828,500,000 | $1,236,300,000 | $1,291,200,000 |
| Gains Losses Not Affecting Retained Earnings | $-32,000,000 | $-44,600,000 | $-27,000,000 | $-35,800,000 |
| Retained Earnings | $-779,900,000 | $-707,000,000 | $-314,900,000 | $-253,100,000 |
| Other Equity Adjustments | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $3,937,000 | - | - | - |
| Ordinary Shares Number | $46,456,462 | $45,962,627 | $46,174,337 | $46,528,907 |
| Share Issued | $50,393,462 | $45,962,627 | $46,174,337 | $46,528,907 |
| Tangible Book Value | $265,500,000 | $260,600,000 | $200,700,000 | $296,700,000 |
| Invested Capital | $878,700,000 | $963,200,000 | $1,404,300,000 | $1,523,700,000 |
| Working Capital | $190,200,000 | $227,500,000 | $252,400,000 | $433,100,000 |
| Capital Lease Obligations | $28,600,000 | $35,500,000 | $41,100,000 | $44,500,000 |
| Total Capitalization | $868,500,000 | $953,800,000 | $1,395,700,000 | $1,517,500,000 |
| Treasury Stock | $102,300,000 | $99,000,000 | $85,900,000 | $66,800,000 |
| Additional Paid In Capital | $1,691,900,000 | $1,678,600,000 | $1,663,600,000 | $1,646,400,000 |
| Capital Stock | $500,000 | $500,000 | $500,000 | $500,000 |
| Common Stock | $500,000 | $500,000 | $500,000 | $500,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $4,000,000 | $4,200,000 | $5,900,000 | $4,800,000 |
| Long Term Capital Lease Obligation | $20,400,000 | $24,600,000 | $28,300,000 | $32,500,000 |
| Current Capital Lease Obligation | $8,200,000 | $10,900,000 | $12,800,000 | $12,000,000 |
| Current Accrued Expenses | $74,400,000 | $73,300,000 | $76,500,000 | $76,600,000 |
| Goodwill | $394,900,000 | $455,600,000 | $796,100,000 | $760,300,000 |
| Net PPE | $141,000,000 | $144,800,000 | $144,000,000 | $146,100,000 |
| Accumulated Depreciation | $-152,100,000 | $-138,700,000 | $-122,900,000 | $-104,800,000 |
| Gross PPE | $293,100,000 | $283,500,000 | $266,900,000 | $250,900,000 |
| Construction In Progress | $25,000,000 | $21,400,000 | $18,000,000 | $16,400,000 |
| Other Properties | $27,600,000 | $34,100,000 | $26,800,000 | $27,500,000 |
| Machinery Furniture Equipment | $199,100,000 | $186,300,000 | $182,800,000 | $168,700,000 |
| Buildings And Improvements | $40,100,000 | $40,600,000 | $38,000,000 | $37,200,000 |
| Land And Improvements | $1,300,000 | $1,100,000 | $1,300,000 | $1,100,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $84,000,000 | $78,300,000 | $88,500,000 | $69,800,000 |
| Work In Process | $25,200,000 | $21,100,000 | $19,800,000 | $23,800,000 |
| Raw Materials | $38,800,000 | $39,400,000 | $54,900,000 | $38,700,000 |
| Foreign Currency Translation Adjustments | - | - | - | - |
| Inventories Adjustments Allowances | - | - | - | - |
Fetched: 2026-06-10
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $43,100,000 | $82,900,000 | $14,600,000 | $71,600,000 |
| Operating Activities | ||||
| Operating Cash Flow | $74,700,000 | $100,700,000 | $32,400,000 | $90,900,000 |
| Cash Flow From Continuing Operating Activities | $74,700,000 | $100,700,000 | $32,400,000 | $90,900,000 |
| Operating Gains Losses | $9,300,000 | $1,200,000 | $72,700,000 | $1,100,000 |
| Investing Activities | ||||
| Capital Expenditure | $-31,600,000 | $-17,800,000 | $-17,800,000 | $-19,300,000 |
| Investing Cash Flow | $-60,600,000 | $-27,500,000 | $21,600,000 | $-135,400,000 |
| Cash Flow From Continuing Investing Activities | $-60,600,000 | $-27,500,000 | $21,600,000 | $-135,400,000 |
| Net Other Investing Changes | $4,000,000 | - | - | - |
| Capital Expenditure Reported | $-31,600,000 | $-17,800,000 | $-17,800,000 | $-19,300,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-3,300,000 | $-12,800,000 | $-19,100,000 | $-45,500,000 |
| Financing Cash Flow | $-37,000,000 | $-49,100,000 | $-94,200,000 | $56,700,000 |
| Cash Flow From Continuing Financing Activities | $-37,000,000 | $-49,100,000 | $-94,200,000 | $56,700,000 |
| Net Common Stock Issuance | $-3,300,000 | $-12,800,000 | $-19,100,000 | $-45,500,000 |
| Net Other Financing Charges | - | $-3,800,000 | $-11,700,000 | $-2,900,000 |
| Other | ||||
| Repayment Of Debt | $-34,400,000 | $-53,600,000 | $-119,700,000 | $-296,600,000 |
| Issuance Of Debt | $0 | $20,000,000 | $55,000,000 | $400,000,000 |
| Interest Paid Supplemental Data | $6,500,000 | $11,500,000 | $14,700,000 | $8,100,000 |
| Income Tax Paid Supplemental Data | $14,100,000 | $3,300,000 | $23,600,000 | - |
| End Cash Position | $89,800,000 | $107,700,000 | $87,700,000 | $127,700,000 |
| Beginning Cash Position | $107,700,000 | $87,700,000 | $127,700,000 | $118,500,000 |
| Effect Of Exchange Rate Changes | $5,000,000 | $-4,100,000 | $200,000 | $-3,000,000 |
| Changes In Cash | $-22,900,000 | $24,100,000 | $-40,200,000 | $12,200,000 |
| Proceeds From Stock Option Exercised | $700,000 | $1,100,000 | $1,300,000 | $1,700,000 |
| Common Stock Payments | $-3,300,000 | $-12,800,000 | $-19,100,000 | $-45,500,000 |
| Net Issuance Payments Of Debt | $-34,400,000 | $-33,600,000 | $-64,700,000 | $103,400,000 |
| Net Long Term Debt Issuance | $-34,400,000 | $-33,600,000 | $-64,700,000 | $103,400,000 |
| Long Term Debt Payments | $-34,400,000 | $-53,600,000 | $-119,700,000 | $-296,600,000 |
| Long Term Debt Issuance | $0 | $20,000,000 | $55,000,000 | $400,000,000 |
| Net Business Purchase And Sale | $-33,000,000 | $-9,700,000 | $39,400,000 | $-116,100,000 |
| Sale Of Business | $0 | $2,100,000 | $89,000,000 | $0 |
| Purchase Of Business | $-33,000,000 | $-11,800,000 | $-49,600,000 | $-116,100,000 |
| Taxes Refund Paid | $-10,400,000 | $-39,400,000 | $-22,400,000 | $0 |
| Change In Working Capital | $20,200,000 | $35,000,000 | $-18,000,000 | $-24,300,000 |
| Change In Payables And Accrued Expense | $-12,300,000 | $-12,300,000 | $-42,100,000 | $28,300,000 |
| Change In Accrued Expense | $-12,900,000 | $-11,400,000 | $-27,700,000 | $-7,100,000 |
| Change In Payable | $600,000 | $-900,000 | $-14,400,000 | $35,400,000 |
| Change In Account Payable | $600,000 | $-900,000 | $-14,400,000 | $35,400,000 |
| Change In Prepaid Assets | $1,400,000 | $14,900,000 | $-19,600,000 | $3,000,000 |
| Change In Inventory | $200,000 | $39,000,000 | $4,700,000 | $-30,900,000 |
| Change In Receivables | $30,900,000 | $-6,600,000 | $39,000,000 | $-24,700,000 |
| Changes In Account Receivables | $30,900,000 | $-6,600,000 | $39,000,000 | $-24,700,000 |
| Stock Based Compensation | $12,600,000 | $13,800,000 | $15,800,000 | $15,900,000 |
| Asset Impairment Charge | $77,000,000 | $436,700,000 | $0 | $0 |
| Depreciation Amortization Depletion | $38,900,000 | $45,500,000 | $46,100,000 | $47,700,000 |
| Depreciation And Amortization | $38,900,000 | $45,500,000 | $46,100,000 | $47,700,000 |
| Gain Loss On Sale Of Business | $0 | $0 | $70,800,000 | $0 |
| Net Income From Continuing Operations | $-72,900,000 | $-392,100,000 | $-61,800,000 | $50,500,000 |
| Amortization Cash Flow | - | - | - | $25,700,000 |
| Amortization Of Intangibles | - | - | - | $25,700,000 |
| Depreciation | - | - | - | $22,000,000 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
| Deferred Tax | - | - | - | - |
| Deferred Income Tax | - | - | - | - |
Fetched: 2026-06-10